IDEAYA Biosciences, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
IDEAYA Biosciences, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to 2023.
  • IDEAYA Biosciences, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $349M, a 11831% increase year-over-year.
  • IDEAYA Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $363M, a 273% increase from 2022.
  • IDEAYA Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $97.2M, a 33.2% decline from 2021.
  • IDEAYA Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $145M, a 13% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $363M +$266M +273% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 $97.2M -$48.3M -33.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 $145M +$16.7M +13% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 $129M +$78.1M +154% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-07
2019 $50.6M -$54.8M -52% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-18
2018 $105M +$87.9M +503% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-23
2017 $17.5M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.